Talking about Health: Why Communication Matters

Talking about Health: Why Communication Matters

Volumn , Issue , 2009, Pages 1-194

  Parrott, Roxanne ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956784707     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444310832     Document Type: Book

References (276)

1. Choi, Y., Choi, S. M., and Rifon, N. (2007, May). "Phantom smokers": The unidentified who do not identify with smokers. A paper presented at the annual meeting of the International Communication Association meeting held in San Francisco, CA, USA.
2. Morten, A., Kohl, M., O'Mahoney, P., and Pelosi, K. (1991). Certified nursemidwifery care of the postpartum client: A descriptive study. Journal of Nurse-Midwifery, 36, 276-288.
3. Li, Q., Kobayashi, M., and Kawada, T. (2008). Relationships between percentage of forest coverage and standardized mortality ratios (SMR) of cancers in all prefectures in Japan. Open Public Health Journal, 1, 1-7.
4. Finkelstein, E. A., Ruhm, C. J., and Kosa, K. M. (2005). Economic causes and consequences of obesity. Annual Review of Public Health, 26, 239-257.
5. Isshiki, Y., Morimoto, K., Nakajima, M., Maruyama, S., and Takeshita, T. (2002). Increasing obesity among male workers in Japan: 1992-1997. Environmental Health and Preventive Medicine, 6, 256-259.
6. Kageyama, Y. (2008, June 8). Japan tackles worker obesity with financial incentives. The Mercury News. Retrieved from www.mercurynews. com/nationworld/ci_9520771, on 6/30/2008.
7. Centers for Disease Control and Prevention, An Ounce of Prevention... What Are the Returns?, 2nd edn (1999, October). Retrieved from www.cdc.gov/epo/prevent.htm, on 9/26/2008.
8. Drewnowski, A., and Specter, S. (2004). Poverty and obesity: Diet quality, energy density, and energy costs. American Journal of Clinical Nutrition, 79, 6-16.
9. Glasgow, R. E., Fisher, E. B., Anderson, B. J., LaGreca, A., Marrero, D., Johnson, S. B., Rubin, R. R., and Cox, D. J. (1999). Behavioral science in diabetes: Contributions and opportunities. Diabetes Care, 22, 832-843.
10. Glasgow, R. E., Wagner, E. H., Kaplan, R. M., Vinicor, F., Smith, L., and Norman, J. (1999). If diabetes is a public health problem, why not treat it as one? A population-based approach to chronic illness. Annals of Behavioral Medicine, 21, 159-170.
11. Thompson, C. L., and Pledger, L. M. (1993). Doctor-patient communication: Is patient knowledge of medical terminology improving? Health Communication, 5, 89-97.
12. Jenkins, V., Leach, L., Fallowfield, L., Nicholls, K., and Newsham, A. (2002). Describing randomization: Patients' and the public's preferences compared with clinicians' practice. British Journal of Cancer, 87, 854-858.
13. Chapman, K., Abraham, C., Jenkins, V., and Fallowfield, L. (2003). Lay understanding of terms used in cancer consultations. Psycho-Oncology, 12, 557-566.
14. Condit, C. M., Condit, D. M., Dubriwny, T., Sefcovic, E., Acosta-Alzura, C., Brown-Givens, S., Dietz, C., and Parrott, R. (2003). Lay understandings of sex/gender and genetics: A methodology that preserves polyvocal coder input. Sex Roles, 49, 557-570.
15. Hall, S., Weinman, J., and Marteau, T. M. (2004). The motivating impact of informing women smokers of a link between smoking and cervical cancer: The role of coherence. Health Psychology, 23, 419-424.
16. Rowe, P. (2003). Why is rickets resurgent in the USA? The Lancet, 357, 1100.
17. Brash, D. E. (1997). Sunlight and the onset of skin cancer. Trends in Genetics, 13, 410-414.
18. US Food and Drug Administration (2008). FDA recommends that overthe-counter (OTC) cough and cold products not be used for infants and children under 2 years of age. Public Health Advisory: Nonprescription Cough and Cold Medicine Use in Children. Retrieved from www.fda.gov/Cder/drug/advisory/cough_cold_2008.htm, on 4/22/08.
19. www.cdc.gov/std/hpv/ScreeningTables.pdf.
20. Caspermeyer, J. J., Sylvester, E. J., Drazkowski, J. F., Watson, G. L., and Sirven, J. I. (2006). Evaluation of stigmatizing language and medical errors in neurology coverage by US newspapers. Mayo Clinical Proceedings, 81, 300-306.
21. Blendon, R. J., Schoen, C., DesRoches, C., Osborn, R., and Zapert, K. (2003). Common concerns amid diverse systems: Health care experiences in five countries. Health Affairs, 22, 106-121.
22. Montgomery, K. S. (2000). Apgar scores: Examining the long-term significance. Journal of Perinatal Education, 9, 5-9.
23. Odd, D. E., Rasmussen, F., Gunnell, D., Lewis, G., and Whitelaw, A. (2007). A cohort study of low Apgar scores and cognitive outcomes. Archives of Disease in Childhood-Fetal and Neonatal Edition, 93, F115-F120.
24. Viswanathan, M. (1993). Measurement of individual differences in preference for numerical information. Journal of Applied Psychology, 78, 741-752.
25. Hallowell, N., Statham, H., Murton, F., Green, J., and Richards, M. (1997). "Talking about chance": The presentation of risk information during genetic counseling for breast and ovarian cancer. Journal of Genetic Counseling, 6, 269-286.
26. Parrott, R., Silk, K., and Condit, C. (2003). Diversity in lay perceptions of the sources of human traits: Genes, environments, and personal behaviors. Social Science and Medicine, 56, 1099-1109.
27. Adelsward, V., and Sachs, L. (1996). The meaning of 6.8: Numeracy and normality in health information talks. Social Science and Medicine, 8, 1179-1187.
28. Covello, V. T., and Peters, R. G. (2002). Women's perceptions of the risks of age-related diseases, including breast cancer: Reports from a three-year research study. Health Communication, 14, 377-395.
29. Wilson, S., Johnston, A., Robson, J., Poulter, N., Collier, D., Feder, G., and Caulfield, M. J. (2003). Comparison of methods to identify individuals at increased risk of coronary disease from the general population. British Medical Journal, 326, 1436-1441.
30. Lobb, E. A., Butow, P. N., Kenny, D. T., and Tattersall, M. H. N. (1999). Communicating prognosis in early breast cancer: Do women understand the language used? Medical Journal of Australia, 171, 290-294.
31. Lussier, G. (1996). Sex and mathematical background as predictors of anxiety and self-efficacy in mathematics. Psychological Reports, 79, 827-833.
32. Betz, N. E. (1978). Prevalence, distribution, and correlates of math anxiety in college students. Journal of Counseling Psychology, 25(5), 441-448.
33. Cooper, S. E., and Robinson, D. A. (1991). The relationship of mathematics self-efficacy beliefs to mathematics anxiety and performance. Measurement and Evaluation in Counseling and Development, 24, 4-11.
34. Newman, K. (2005). The case for the narrative brain. ACM International Conference Proceeding Series, 23, 145-149.
35. Mathieson, C. M. and Stam, H. J. (1995). Renegotiating identity: Cancer narratives. Sociology of Health and Illness, 17, 283-306.
36. Ochs, E. and Capps, L. (1996). Narrating the self. Annual Review of Anthropology, 25, 19-43.
37. American Cancer Society, Support for survivors and patients (2008). Retrieved from http:www.cancer.org/docroot/SHR/SHR_0.asp, on 9/11/2008.
38. Salander, P. (2002). Bad news from the patient's perspective: An analysis of the written narratives of newly diagnosed cancer patients. Social Science and Medicine, 55, 721-732.
39. Gotcher, J. M. (1995). Well-adjusted and maladjusted cancer patients: An examination of communication variables. Health Communication, 7, 21-33.
40. Bylund, C. L. (2005). Mothers' involvement in decision making during the birthing process: A quantitative analysis of women's online birth stories. Health Communication, 18, 23-39.
41. Sepucha, K. R., Belkora, J. K., Mutchnick, S., and Esserman, L. J. (2002). Consultation planning to help breast cancer patients prepare for medical consultations: Effect on communication and satisfaction for patients and physicians. Journal of Clinical Oncology, 20, 2695-2700.
42. Parrott, R., Volkman, J., Ghetian, C., Weiner, C., Weiner, J., Raup-Krieger, J., and Parrott, J. (2008). Memorable messages about genes and health: Implications for direct-to-consumer marketing of genetics tests and therapies. Health Marketing Quarterly, 25(1), 1-25.
43. Singer, J. A. (2004). Narrative identity and meaning making across the adult lifespan: An introduction. Journal of Personality, 72, 437-460.
44. Curlin, F. A., Roach, C. J., Gorawara-Bhat, R., Lantos, J. D., and Chin, M. H. (2005). When patients choose faith over medicine: Physician perspectives on religiously related conflict in the medical encounter. Archives of Internal Medicine, 165, 88-91.
45. Centers for Disease Control and Prevention (1993, July 16). Lead poisoning associated with use of traditional ethnic remedies-California, 1991-1992. Morbidity and Mortality Weekly Report, 42, 521-524.
46. Ouellette, J. A., and Wood, W. (1998). Habit and intention in everyday life: The multiple processes by which past behavior predicts future behavior. Psychological Bulletin, 124, 54-74.
47. Schreiber, L. (2005). The importance of precision in language: Communication research and (so-called) alternative medicine. Health Communication, 17, 173-190.
48. Committee on the Use of Complementary and Alternative Medicine (2005). Complementary and Alternative Medicine in the United States. Washington, DC: The National Academies Press.
49. Conner, M., Kirk, S. F., Cade, J. E., and Barrett, J. H. (2001). Why do women use dietary supplements? The use of the theory of planned behaviour to explore beliefs about their use. Social Science and Medicine, 52, 621-633.
50. Clegg, D. O., Reda, D. J., Harris, C. L., Klein, M. A., O'Dell, J. R., Hooper, M. M., Bradley, J. D., Bingham III, C. O., Weisman, M. H., Jackson, C. G., Lane, N. E., Cush, J. J., Moreland, J. W., Schumacher, R., Oddis, C. V., Wolfe, F., Molitor, J. A., Yocum, D. E., Scnitzer, T. J., Furst, D. E., Sawitzke, A. D., Shi, H., Brandt, K. D., Moskowitz, R. W., and Williams, H. J. (2006). Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. New England Journal of Medicine, 354, 795-808.
51. Howell, L., Kochhar, K., Saywell, R., Zollinger, T., Koehler, J., Mandzuk, C., Sutton, B., Sevilla-Martir, J., and Allen, D. (2006). Use of herbal remedies by Hispanic patients: Do they inform their physician? Journal of the American Board of Family Physicians, 19, 566-578.
52. American Occupational Therapy Association, Inc., Living with spinal cord injury (SCI). Retrieved from www.aota.org/Consumers/Tips/Conditions/SCI/35189.aspx, on 9/11/2008.
53. Parrott, R., Stuart, T., and Cairns, A. B. (2000). Reducing uncertainty through communication during adjustment to disability: Living with spinal cord injury. In D. O. Braithwaite and T. L. Thompson (eds), Handbook of Communication and People with Disabilities: Research and application (pp. 339-352). Mahwah, NJ: Lawrence Erlbaum.
54. Kaplowitz, S. A., Campo, S., and Chiu, W. T. (2002). Cancer patients' desires for communication of prognosis information. Health Communication, 14, 221-241.
55. Ajaj, A., Singh, M. P., and Abdulla, A. J. J. (2001). Should elderly patients be told they have cancer? Questionnaire survey of older people. British Medical Journal, 323, 1160.
56. Houldin, A. D. (2007). A qualitative study of caregivers' experiences with newly diagnosed advanced colorectal cancer. Oncology Nursing Forum, 34, 323-330.
57. Gray, R. E., Fitch, M., Phillips, C., Labrecque, M., and Fergus, K. (2000). To tell or not to tell: Patterns of disclosure among men with prostate cancer. Psycho-Oncology, 9, 273-282.
58. Arrington, M. I. (2005). "She's right behind me all the way": An analysis of prostate cancer narratives and changes in family relationships. Journal of Family Communication, 5, 141-162.
59. Kendall, S., (2006). Being asked not to tell: Nurses' experiences of caring for patients not told their diagnosis. Journal of Clinical Nursing, 15, 1149-1157.
60. Keeley, M. P., and Yingling, J. M. (2007). Final Conversations: Helping the living and the dying talk to each other. Acton, MA: Van Wyk and Burnham.
61. Gaskin, D. J., Kong, J., Meropol, N. J., Yabroff, K. R., Weaver, C., and Schulman, K. A. (1998). Treatment choices by serious ill patients. Medical Decision Making, 18, 84-94.
62. Parle, M., Maguire, P., and Heaven, C. (1997). The development of a training model to improve health professionals' skills, self-efficacy and outcome expectancies when communicating with cancer patients. Social Science and Medicine, 44, 231-240.
63. Wysocki, T., Green, L., and Huxtable, K. (1989). Blood glucose monitoring by diabetic adolescents: Compliance and metabolic control. Health Psychology, 8, 267-284.
64. Gray, J. A. (1982). The Neuropsychology of Anxiety: An enquiry into the functions of the septo-hippocampal system. New York: Oxford University Press.
65. Carver, C. S. and White, T. L. (1994). Behavioral inhibition, behavioral activation, and affective responses to impending reward and punishment: The BIS/BAS scales. Journal of Personality and Social Psychology, 67, 319-333.
66. Luciana, M., Collins, P. F., and Depue, R. A. (1992). Opposing roles for dopamine and serotonin in the modulation of human spatial working memory functions. Cerebral Cortex, 8, 218-226.
67. Corrigall, W. A., Coen, K. M., and Adamson, K. L. (1994). Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Research, 653, 278-284.
68. Rodway, P., Dienses, Z., and Schepman, A. (2000). The effects of cigarette smoking on negative priming. Experimental and Clinical Psychopharmacology, 8, 104-111.
69. Jorm, A. F., Christensen, H., Henderson, A. S., Jacomb, P. A., Korten, A. E., and Rodgers, B. (1998). Using the BIS/BAS scales to measure behavioural inhibition and behavioural activation: Factor structure, validity and norms in a large community sample. Personality and Individual Differences, 26, 49-58.
70. Cooper, M. L., Agocha, V. B., and Sheldon, M. S. (2000). A motivational perspective on risky behaviors: The role of personality and affect regulatory processes. Journal of Personality, 68, 1059-1088.
71. McFarland, B. R., Shankman, S. A., Tenke, C. E., Bruder, G. E., and Klein, D. N. (2006). Behavioral activation system deficits predict the sixmonth course of depression. Journal of Affective Disorders, 91, 229-234.
72. Gray 1982; Carver and White 1994: see 63 and 64 above.
73. Spoont, M. R. (1992). Modulatory role of serotonin in neural information processing: Implications for human psychopathology. Psychological Bulletin, 11, 330-350.
74. Luciana et al. 1998. See 65 above.
75. Henriksen, L., and Jackson, C. (1998). Anti-smoking socialization: Relationship to parent and child smoking status. Health Communication, 10, 87-101.
76. Kambouropoulos, N., and Staiger, P. K. (2004). Reactivity to alcoholrelated cues: Relationship among cue type, motivational processes, and personality. Psychology of Addictive Behaviors, 18, 275-283.
77. Lobb et al. (1999). See 29 above.
78. Clayton, R. R., Segress, M. J. H., and Caudill, C. A. (2007). Sensationseeking: A commentary. Addiction, 102, 92-94.
79. Holtgrave, D. R., Tinsley, B. J., and Kay, L. S. (1995). Encouraging risk reduction: A decision-making approach to message design. In E. Maibach and R. Parrott (eds.), Designing Health Messages: Approaches from communication theory and public health practice (pp. 24-40). Thousand Oaks, CA: Sage.
80. Netter, P., Hennig, J., and Roed, I. S. (1996). Serotonin and dopamine as mediators of sensation seeking behavior. Biological Psychology/Pharmacopsychology, 34, 155-165.
81. Zuckerman, M. (1990). The psychophysiology of sensation seeking. Journal of Personality, 58, 313-345.
82. Donohew, L., Zimmerman, R., Cupp, P. S., Novak, S., Colon, S., and Abell, R. (2000). Sensation seeking, impulsive decision-making, and risky sex: Implications for risk-taking and design of interventions. Personality and Individual Differences, 28, 1079-1091.
83. Kassinove, J. I. (1998). Development of the gambling attitude scales: Preliminary findings. Journal of Clinical Psychology, 54, 763-771.
84. Laucht, M., Becker, K., and Schmidt, M. H. (2006). Visual exploratory behaviour in infancy and novelty seeking in adolescence: Two developmentally specific phenotypes of DRD4? Journal of Child Psychology and Psychiatry, 47, 1143-1151.
85. Niederdeppe, J., Davis, K. C., Farrelly, M. C., and Yarsevich, J. (2007). Stylistic features, need for sensation, and confirmed recall of national smoking prevention advertisements. Journal of Communication, 57, 272-292.
86. Sirois, F. M. (2006). "I'll look after my health later": A replication and extension of the procrastination-health model with community-dwelling adults. Personality and Individual Differences, 43, 15-26.
87. Miller, S. M., Siejak, K. K., Schroeder, C. M., Lerman, C., Hernandez, E., and Helm, C. W. (1997). Enhancing adherence following abnormal Pap smears among low-income minority women: A preventive telephone counseling strategy. Journal of the National Cancer Institute, 89, 703-708.
88. Passanisi, N., Prout, M., and Holm, L. J. (2001). The New England division "Tell a Friend" program implementation evaluation. Cancer Practice, 9 (Suppl. 1), S64-S71.
89. Davis, T. C., Wolf, M. S., Bass, P. F., Middlebrooks, M., Kennen, E., Baker, D. W., Bennette, C. L., Durazo-Arvizu, R., Bocchini, A., Savory, S., and Parker, R. M. (2006). Low literacy impairs comprehension of prescription drug warning labels. Journal of General Internal Medicine, 21, 847-851.
90. Scheitel, S. M., Boland, B. J., Wollan, P. C., and Silverstein, M. D. (1996). Patient-physician agreement about medical diagnoses and cardiovascular risk factors in the ambulatory general medical examination. Mayo Clinical Proceedings, 71, 1131-1137.
91. Parrott, R., Monahan, J., Ainsworth, S., and Steiner, C. (1998). Communicating to farmers about skin cancer: A behavioral adaptation model. Human Communication Research, 24, 386-409.
92. Schneider, A., and McCumber, D. (2005). An Air that Kills: How the asbestos poisoning of Libby, Montana, uncovered a national scandal. New York: Penguin Books.
93. Chatters, L. M., Levin, J. S., and Taylor, R. J. (1992). Antecedents and dimensions of religious involvement among older black adults. Journal of Gerontology, 47 (suppl.), 269-278.
94. Kerr, A., Cunningham-Burley, S., and Amos, A. (1998). Drawing the line: An analysis of lay discussions about the new genetics. Public Understanding of Science, 7, 113-133.
95. Harris, T., Parrott, R., and Dorgan, K. (2004). Talking about human genetics within religious frameworks. Health Communication, 16(1), 105-116.
96. Parrott, R., Silk, K., Krieger, J. R., Harris, T., and Condit, C. (2004). Behavioral health outcomes associated with religious faith and media exposure about human genetics. Health Communication, 16(1), 29-46.
97. Ellison, C. G., and Goodson, P. (1997). Conservative Protestantism and attitudes toward family planning in a sample of seminarians. Journal for the Scientific Study of Religion, 36, 512-529.
98. Franken, I. H. A., and Muris, P. (2006). BIS/BAS personality characteristics and college students' substance use. Personality and Individual Differences, 40, 1497-1503.
99. Soweid, R. A. A., Khawaja, M., and Salem, M. T. (2004). Religious identity and smoking behavior among adolescents: Evidence from entering students at the American University of Beirut. Health Communication, 16, 47-62.
100. Sloan, R. P., Bagiella, E., and Powell, T. (1999). Religion, spirituality, and medicine. The Lancet, 353, 664-667.
101. Peters, T. (1997). Playing God? Genetic determinism and human freedom. New York: Routledge.
102. Valenti, J. M. (2002). Communication challenges for science and religion. Public Understanding of Science, 11, 57-63.
103. Ross, S., Grant, A., Counsell, C., Gillespie, W., Russell, I., and Prescott, R. (1999). Barriers to participation in randomized controlled trials: Literature summary and annotated bibliography. Journal of Clinical Epidemiology, 52, 1143-1156.
104. Gostin, L. O. (1995). Informed consent, cultural sensitivity, and respect for persons. Journal of the American Medical Association, 274, 844-845.
105. Sugarman, J., and Powers, M. (1991). How the doctor got gagged. The disintegrating right of privacy in the physician-patient relationship. Journal of the American Medical Association, 266, 3323-3327.
106. Milone, S. D., and Milone, S. L. (2006). Evidence-based periodic health examination of adults: Memory aid for primary care physicians. Canadian Family Physician, 10, 40-47.
107. Davidhizar, R., and Giger, J. N. (1994). A review of the literature on care of clients in pain who are culturally diverse. International Nursing Review, 51, 47-55.
108. Speice, J., Harkness, J., Laneri, H., Frankel, R., Roter, D., Kornblith, A. B., Ahles, T., Winer, E., Fleishman, S., Luber, P., Zevon, M., McQuellon, R., Trief, P., Finkel, J., Spira, J., Greenberg, D., Towland, J., and Holland, J. C. (2000). Involving family members in cancer care: Focus group considerations of patients and oncological providers. Psycho-Oncology, 9, 101-112.
109. Leydon, G. M., Bynoe-Sutherland, J., and Coleman, M. P. (2003). The journey towards a cancer diagnosis: The experiences of people with cancer, their family and carers. European Journal of Cancer Care, 12, 317-326.
110. Majerovitz, S. D., Greene, M. G., Adelman, R. D., Brody, G. M., Leber, K., and Healy, S. W. (1997). Older patients' understanding of medical information in the emergency department. Health Communication, 9, 237-251.
111. Morisky, D. E., DeMuth, N. M., Field-Fass, M., Green, L. W., and Levine, D. M. (1985). Evaluation of family health education to build social support for long-term control of high blood pressure. Health Education Quarterly, 12, 35-50.
112. Korhonen, T., Uutela, A., Korhonen, H. J., and Puska, P. (1998). Impact of mass media and interpersonal health communication on smoking cessation attempts: A study in North Karelia, 1989-1996. Journal of Health Communication, 3, 105-118.
113. Committee on the Consequences of Uninsurance (2002). Health Insurance Is a Family Matter. Washington, DC: The National Academies Press.
114. Stiggelbout, A. M., Jansen, S. J. T., Otten, W., Baas-Thijssen, M. C. M., van Slooten, H., and van de Velde, C. J. J. (2007). How important is the opinion of significant others to cancer patients' adjuvant chemotherapy decision-making? Supportive Care in Cancer, 15, 319-325.
115. Koerner, A. F., and Cvancara, K. E. (2002). The influence of conformity orientation on communication patterns in family conversations. Journal of Family Communication, 2, 133-152.
116. Lewin, S. A., Babigumira, S. M., Bosch-Capblanch, X., van Wyk, A. G., Glenton, C., Scheel, I., Zwarenstein, M., and Daniels, K. (2006, November). Lay health workers in primary and community health care: A systematic review of trials. Retrieved from (www.who.int/rpc/meetings/LHW_review.pdf), on 9/26/2008.
117. Baldwin, J. R., Faulkner, S., Hecht, M., Lindsley, S. L. (2005). Redefining Culture: Perspectives across the disciplines. Mahwah, NJ: Lawrence Erlbaum Associates.
118. Airhihenbuwa, C. O., Makinwa, B., and Obregon, R. (2000). Toward a new communications framework for HIV/AIDS. Journal of Health Communication, 5, 101-111.
119. Brown, P., Levinson, S. C., and Gumperz, J. L. (1987). Politeness: Some universals in language usage. New York: Cambridge University Press.
120. Horwitz, S. M., Leaf, P. J., and Leventhal, J. M. (1998). Identification of psychosocial problems in pediatric primary care. Archives of Pediatric Adolescent Medicine, 152, 367-371.
121. Majerovitz et al. 1997. See 109 above.
122. Chapple, A., and Ziebland, S. (2002). Prostate cancer: Embodied experience and perceptions of masculinity. Sociology of Health and Illness, 24, 820-841.
123. Weiner, J. L., Silk, K. J., and Parrott, R. L. (2005). Family communication and genetic health: A research note. Journal of Family Communication, 5, 313-324.
124. Johnson, J. L., Bottorff, J. L., and Browne, A. J. (2004). Othering and being othered in the context of health care services. Health Communication, 16, 253-271.
125. Weinstein, N. D. (1987). Unrealistic optimism about susceptibility to health problems: Conclusions from a community-wide sample. Journal of Behavioral Medicine, 10, 481-500.
126. Horswill, M. S., and Mckenna, F. P. (1999). The effect of perceived control on risk taking. Journal of Applied Social Psychology, 29, 377-391.
127. Arnett, J. J. (2000). Optimistic bias in adolescent and adult smokers and nonsmokers. Addictive Behaviors, 25, 625-632.
128. Weinstein, N. D. (1982). Unrealistic optimism about susceptibility to health problems. Journal of Behavioral Medicine, 5, 441-460.
129. Renn, O., Burns, W. J., Kasperson, J. X., Kasperson, R. E., and Slovic, P. (1992). The social amplification of risk: Theoretical foundations and empirical applications. Journal of Social Issues, 48, 137-160.
130. Glasgow, Fisher, et al.; Glasgow, Wagner, et al. See 9 above.
131. Zuckerman, B., Stevens, G. D., Inkelas, M., and Halfon, N. (2004). Prevalence and correlates of high-quality basic pediatric preventive care. Pediatrics, 114, 1522-1529.
132. Covello and Peters (2002). See 27 above.
133. LeGales, C., Bougerol, C., Fainzang, S., Seror, V., Galacteros, F., Bardakdjian, J., and Assaba, C. (1993). Economic assessment of newborn screening for sickle cell disease in France. Abstracts of the International Society of Technological Assessments in Health Care Meeting, 9, 163.
134. Patch, C. (2006). Newborn screening policy in the United Kingdom and the United States: Two different communities of practice. American Journal of Maternal and Child Nursing, 31, 164-168. March of Dimes, Professionals and Researchers: Clinical issues and considerations. Newborn screening: Introduction and history. Retrieved from www. marchofdimes.com/printableArticles/24279_9606.asp, 9/18/2008.
135. Welcome to the UK Newborn Screening Programme Centre. Retrieved from www.newbornscreening-bloodspot.org.uk, on 7/9/2008.
136. Centers for Disease Control and Protection, Nationally notifiable infectious diseases. Retrieved from www.cdc.gov/ncphi/disss/nndss/phs/infdis.htm, on 9/25/2008.
137. Parrott, R., Silk, K., Dillow, M., Krieger, J., Harris, T., and Condit, T. (2005). The development and validation of tools to assess perceptions of genetic discrimination and genetic racism. Journal of the National Medical Association, 97, 980-991.
138. Salmon, D. A., Haber, M., Gangaros, E. J., Phillips, L., Smith, N. J., and Chen, R. T. (1999). Health consequences of religious and philosophical exemptions from immunization laws. Journal of the American Medical Association, 282, 47-53.
139. McIlroy, C. (2004). Issue brief: Bioterrorism and state public health laws-new challenges. Retrieved from www.nga.org/cda/files/0405BIOTERRORISMLAWS.pdf, on 9/23/2008.
140. Apollonio, D. E., and Bero, L. A. (2007). Protecting the public from environmental hazards: The creation of industry front groups: The tobacco industry and "get government off our back." American Journal of Public Health, 97, 419-427.
141. Sinclair, U. (1906). The Jungle. New York: Doubleday.
142. US Food and Drug Administration, Center for Drug Evaluation and Research, Investigational new drug (IND) application process. Retrieved from www.fda.gov/cder/Regulatory/applications/ind_page_1.htm, on 9/21/2008.
143. Drake, A. W., Finkelstein, S. N., and Sapolsky, H. M. (1982). The American Blood Supply: Issues and policies of blood donation. Health and public policy. Cambridge, MA: MIT Press.
144. Lyme disease and babesiosis blood donations: Blood donation centers. Retrieved from www.lymeinfo.net/bloodtransfusions.html, on 7/11/2008.
145. Engholm, G., Palmgren, F., and Lynge, E. (1996). Lung cancer, smoking, and environment: A cohort study of the Danish population. British Medical Journal, 312, 1259-1263.
146. US Environmental Protection Agency, Asthma and indoor environments: About asthma. Retrieved from www.epa.gov/ashthma/about.html, on 10/28/2006.
147. US Environmental Protection Agency, The Safe Drinking Water Act and lead in drinking water. Retrieved from www.epa.gov/safewater/lcmr/lead_nsfstandard.html, on 7/11/2008.
148. European Public Health Alliance, Update 67: Water: Preventing a crisis. Retrieved from www.epha.org/a/276 on 7/16/2008.
149. Hammond, D., Fong, G. T., Borland, R., Cummings, K. M., McNeil, A., and Driezen, P. (2007). Text and graphic warnings on cigarette packages: Findings from the international tobacco control four country study. American Journal of Preventive Medicine, 32, 202-209.
150. De Turck, M. (2002). Persuasive effects of product warning labels. In J. P. Dillard and M. Pfau (eds), The Persuasion Handbook: Developments in theory and practice (pp. 345-370). Thousand Oaks, CA: Sage.
151. Cantrill, J. G. (1993). Communication and our environment: Categorizing research in environmental advocacy. Journal of Applied Communication Research, 21(1), 66-95.
152. Cantrill, J. G. (1998). The environmental self and a sense of place: Communication foundations for regional ecosystem management. Journal of Applied Communication Research, 26, 301-318.
153. Miller, K., and Zook, E. G. (1997). Care partners for persons with AIDS: Implications for health communication. Journal of Applied Communication Research, 25, 57-74.
154. Juniata Clean Water Partnership. Retrieved from www.jcwp.org/, on 9/23/2008.
155. Thompson, T. and Parrott, R. (2002). Interpersonal communication and health care. In M. Knapp and J. Daly (eds), Handbook of Interpersonal Communication, 3rd edn (pp. 680-725). Thousand Oaks, CA: Sage.
156. Pratt, C. B., Ha, L., and Pratt, C. A. (2002). Setting the public health agenda on major diseases in sub-Saharan Africa: African popular magazines and medical journals, 1981-1997. Journal of Communication, 52, 889-904.
157. Sandman, P. M., Weinstein, N. D., and Klotz, M. L. (1987). Public response to the risk from geological radon. Journal of Communication, 37(3), 93-108.
158. Callahan, D., and Jennings, B. (2002). Ethics and public health: Forging a strong relationship. American Journal of Public Health, 92, 169-176.
159. UK pharma: Key player-AstraZeneca. Retrieved from www.eiu.com/index.asp?layout=ib3Article&article_id=2003904185&pubtypeid= 1152462500&rf=0 on 12/21/2008.
160. Dens, N., Eagle, L. C., and De Pelsmacker, P. (2008). Attitudes and selfreported behavior of patients, doctors, and pharmacists in New Zealand and Belgium toward direct-to-consumer advertising of medication. Health Communication, 23, 45-61.
161. Davis, J. J., Cross, E., and Crowley, J. (2007). Pharmaceutical websites and the communication of risk information. Journal of Health Communication, 12, 29-39.
162. Kravitz, R. L., Epstein, R. J., Feldman, M. D., Franz, C. E., Azari, R., Wilkes, M. S., Hinton, L., and Franks, P. (2005). Influence of patients' requests for direct-to-consumer advertised antidepressants: A randomized controlled trial. Journal of the American Medical Association, 293, 1995-2002.
163. Hollon, M. F. (1999). Direct-to-consumer marketing of prescription drugs: A current perspective for neurologists and psychiatrists. CNS Drugs, 18, 69-77.
164. Abel, G. A., Penson, R. T., Joffe, S., Schapira, L., Chabner, B. A., and Lynch, T. J. (2007). Direct-to-consumer advertising in oncology. The Oncologist, 11, 217-226.
165. Lyon, A. (2007). "Putting patients first": Systematically distorted communication and Merck's marketing of Vioxx. Journal of Applied Communication Research, 35, 376-398.
166. Freimuth, V. S., Hammond, S. L., and Stein, J. A. (1988). Health advertising: Prevention for profit. American Journal of Public Health, 78, 557-561.
167. Smith, S. C., Taylor, J. G., and Stephen, A. M. (1999). Use of food labels and beliefs about diet-disease relationships among university students. Public Health Nutrition, 3, 175-182.
168. Food Safety Authority of Ireland (2007). The labelling of food in Ireland. Retrieved from www.fsai.ie/publications/reports/labelling2007.pdf, on 7/16/2008.
169. Better labeling urged after teen's sports cream overdoes: BenGay maker says it is safe when used as directed (2007, June 12). Retrieved from http://seattlepi.nwsource.com/printer2/index.asp?ploc=tandrefer=http://seattlepi.nwsource.com/health/319572_cream13.html, on 9/24/2008.
170. Wang, Z., and Gantz, W. (2007). Health content in local television news. Health Communication, 21, 213-221.
171. Slattery, K., Doremus, M., and Marcus, L. (2001). Shifts in public affairs reporting on the network evening news: A move toward the sensational. Journal of Broadcasting and Electronic Media, 45, 290-302.
172. Bell, A. (1991). The Language of News Media. Cambridge, MA: Basil Blackwell.
173. Moyer, A., Greener, S., Beauvais, J., and Salovey, P. (1995). Accuracy of health research reported in the popular press: Breast cancer mammography. Health Communication, 7, 147-161.
174. Pellechia, M. G. (1997). Trends in science coverage: A content analysis of three US newspapers. Public Understanding of Science, 6, 49-68.
175. Conrad, P. (1999). Uses of expertise: Sources, quotes, and voice in the reporting of genetics in the news. Public Understanding of Science, 8, 285-302.
176. Hoskins, K. F., Stopfer, J. E., Calzone, K. A., Merajver, S. D., Rebbeck, T. R., Garber, J. E., and Weber, B. L. (1995). Assessment and counseling for women with a family history of breast cancer: A guide for clinicians. Journal of the American Medical Association, 273, 577-585.
177. Sundar, S. S. (2000). Conceptualizing sources in online news. Journal of Communication, 51, 52-72.
178. Bahk, C. M. (2001). Drench effects of media portrayal of fatal virus disease on health locus of control beliefs. Health Communication, 13, 187-204.
179. Parrott et al. 2008., See 41 above.
180. Centers for Disease Control and Prevention, Health Marketing-Healthstyles Survey. Retrieved from www.cdc.gov/HealthMarketing/entertainment_education/healthstyles_survey.htm, on 9/24/2008.
181. Outley, C. W. and Taddese, A. (2006). A content analysis of health and physical activity messages marketed to African American children during after-school television programming. Archives of Pediatrics and Adolescent Medicine, 160, 432-435.
182. Galician, M. L. (2004). Product placement in the mass media: Unholy marketing marriages or realistic story-telling portrayals, unethical advertising messages or useful communication practices? Journal of Promotion Management, 10(1), 1-8.
183. Brandcameo-films. Retrieved from www.brandchannel.com/brandcameo_films.asp, on 9/24/2008.
184. Interbrand: Creating and managing brand value. Retrieved from www.interbrand.com, on 9/21/2008.
185. Siegel, P. (2004). Product placement and the law. Journal of Promotion Management, 10(1), 89-100.
186. Hazan, A. R., and Glantz, S. A. (1995). Current trends in tobacco use on prime-time fictional television. American Journal of Public Health, 85, 116-117.
187. McGee, R., and Ketchel, J. (2006). Tobacco imagery on New Zealand television: 2002-2004. Tobacco Control, 15, 412-414.
188. Mathios, A., Averty, R., Biscogni, C., and Shanahan, J. (1998). Alcohol portrayal on prime-time television: Manifest and latent messages. Journal of Studies on Alcohol, 59, 305-310.
189. Signorielli, N., and Lears, M. (1992). Television and children's conceptions of nutrition: Unhealthy messages. Health Communication, 4, 245-257.
190. Greenberg, B. S., Eastin, M., Hofschire, L., Lachlan, K., and Brownell, K. D. (2003). Portrayals of overweight and obese individuals on commercial television. American Journal of Public Health, 93, 1342-1348.
191. Galician 2004. See 180 above.
192. The Communication Initiative Network: Hollywood, Health & Society-United States. Retrieved from www.comminit.com/en/node/123490, on 9/21/2008.
193. Wilson, K. E., and Beck, V. H. (2002). Entertainment outreach for women's health at CDC. Journal of Women's Health and Gender-Based Medicine, 11, 575-578.
194. Boden, W. E., and Diamond, G. A. (2008). DTCA for PTCA-Crossing the line in consumer health education? New England Journal of Medicine, 358, 2197-2200.
195. Stevenson, H. W., Lee, S. Y., and Stigler, J. W. (1986). Mathematics achievement of Chinese, Japanese, and American children. Science, 231, 693-699.
196. Salili, F. (1996). Accepting personal responsibility for learning. In D. A. Watkins and J. B. Biggs (eds), The Chinese Learner: Cultural, psychological and contextual influences (pp. 85-105). Hong Kong and Melbourne: Comparative Education Resource Center (CERC) and Australian Council for Educational Research (ACER).
197. Williams, M. V., Parker, R. M., Baker, D. W., Parikh, N. S., Pitkin, K., Coates, W. C., and Nurss, J. R. (1995). Inadequate functional health literacy among patients at two public hospitals. Journal of the American Medical Association, 274, 1677-1682.
198. Reys, B. J., Dingman, S., Nevels, N., and Teuscher, D. (2007). High school mathematics: State-level curriculum standards and graduation requirements. Center for the Study of Mathematics Curriculum. Retrieved from www.mathcurriculumcenter.org/PDFS/HSreport.pdf, on 9/24/2008.
199. Cooper, C. P., and Yukimura, D. (2002). Science writers' reactions to a medical "breakthrough" story. Social Science and Medicine, 54, 1887-1896.
200. Levin, A. (2001). The Cochrane collection. Annals of Internal Medicine, 135, 309-312.
201. Markman, M., Petersen, J., and Montgomery, R. (2006). Influence of tumor type, disease status, and patient age on self-reported interest regarding participation in cancer clinical trials. Cancer, 107, 849-853.
202. FDA drug approval process. Retrieved from www.chemcases.com/cisplat/cisplat15.htm, retrieved on 9/24/2008.
203. Raup-Krieger, J., Parrott, R., and Nussbaum, J. (under review). An empirical test of metaphors as a strategy for creating culturally appropriate messages. Journal of Health Communication.
204. Moseley, J. B., O'Malley, K., Petersen, N. J., Menke, T. J., Brody, B. A., Kuykendall, D. H., Hollingsworth, J. C., Ashton, C. M., and Wray, N. P. (2002). A controlled trial of arthroscopic surgery for osteoarthritis of the knee. New England Journal of Medicine, 347, 81-88.
205. Bhattaram, V. A., Booth, B. P., Ramchandani, R. P., Beasley, B. N., Wang, Y., Tandon, V., Duan, J. Z., Baweja, R. K., Marroum, P. J., Uppoor, R. S., Rahman, N. A., Sahajwall, C. G., Powell, J. R., Mehta, M. U., and Gobburu, J. V. S. (2005). Impact of pharmacometrics on drug approval and labeling decisions: A survey of 42 new drug applications. AAPS Journal, 7, E503-E5112.
206. Gardin, J. M., Schumacher, D., Constantine, G., Davis, K. D., Leung, C., and Reid, C. L. (2000). Valvular abnormalities and cardiovascular status following exposure to dexfenfluramine or phentermine/fenfluramine. Journal of the American Medical Association, 283, 1703-1709.
207. Sachdev, M., Miller, W. C., Ryan, T., and Jollis, J. G. (2002). Effect of fenfluamine-derivative diet pills on cardiac valves: A meta-analysis of observational studies. American Heart Journal, 144, 1065-1073.
208. Chen, D. A., Backous, D. D., Arriaga, M. A., Garvin, R., Kobyle, D., Littman, T., Walgren, S., and Lura, D. (2004). Phase 1 clinical trial results of the envoy system: A totally implantable middle ear device for sensorineural hearing loss. Otolaryngology-Head and Neck Surgery, 131, 904-916.
209. Rodriuez, E., DePuelles, P. E., and Jovell, A. J. (1999). The Spanish health care system: Lessons for newly industrialized countries. Health Policy and Planning, 14, 164-173.
210. Embassy of France (2007, January 10). The French healthcare system. Retrieved from www.info-france-usa.org.atoz/health.asp, on 1/10/2007.
211. Drexler, M. (2003). Health Disparities and the Body Politic: A series of international symposia. Boston, MA: Harvard School of Public Health. Retrieved from www.hsph.harvard.edu/disparities/book/index.html, on 9/25/2008.
212. The color of research. Retrieved from www.tufts.edu/home/feature/?p=tuskegee, on 7/25/2008.
213. Dober, G. (2008). Cheaper than chimpanzees: Expanding the use of prisoners in medical experiments. Prison Legal News. Retrieved from www.prisonlegalnews.org/displayArticle.aspx?articleid=19630&AspxAuto DetectCookieSupport=1, on 9/25/2008.
214. Institute of Medicine (2006). Ethical Considerations for Research Involving Prisoners. Washington DC: National Academies Press.
215. Eslocker, A. R., and Hill, A. (2006, July 7). Artificial blood experiment: Is your city participating? Retrieved from http://abcnews.go.com/WNT/story?id=2166058&page=1&WNT=true, on 9/25/2008.
216. Natanson, C., Kern, S. J., Lurie, P., Banks, S. M., and Wolfe, S. M. (2008). Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death. Journal of the American Medical Association, 299, 2304-2312.
217. Medical News Today (2008, July 10). Largest international cardiac surgery study will compare open-heart surgery with or without heart-lung machine. Retrieved from www.medicalnewstoday.com/printerfriendlynews.php?newsid=114476, on 7/24/2008.
218. National Conference of State Legislatures (2007, November). Pharmacist conscience clauses: Laws and legislation. Retrieved from www.ncsl.org/programs/health/ConscienceClauses.htm, on 9/25/2008.
219. Hyde, M. J., and Rufo, K. (2000). The call of conscience, rhetorical interruptions, and the euthanasia controversy. Journal of Applied Communication Research, 28(1), 1-23.
220. Griffiths, J. (2008). Physician-assisted suicide in the Netherlands and Belgium. In D. Birnbacher and E. Dahl (eds), Giving Death a Helping Hand: Physician-assisted suicide and public policy. An international perspective (pp. 77-86). Dordrecht, The Netherlands: Springer.
221. Teri Schiavo. Retrieved from http://news.findlaw.com/legalnews/lit/schiavo/, on 9/25/2008.
222. Paillaud, E., Ferrand, E., Lejonc, J., Henry, O., Bouillanne, O., and Montagne, O. (2007). Medical information and surrogate designation: Results of a prospective study in elderly hospitalized patients. Age and Ageing, 36, 274-279.
223. American Medical Association (2007). Position statement: Direct-toconsumer advertising. Retrieved from www.ama.com.au/web.nsf/doc/WEEN-7AM7CH, on 7/26/2008.
224. Mishra, S. K. (2005, August 29). Telemedicine: Experience at a tertiary care hospital. Enterprise networking and computing in healthcare industry. Proceedings of the 7th International Workshop. Retrieved from http://ieeexplore.ieee.org/xpl/freeabs_all.jsp?arnumber=1500370, on 9/25/2008.
225. Harris, C. P. (1999). Lobbying and public affairs in the UK: The relationship to political marketing. PhD thesis, Manchester Metropolitan University. Retrieved from http://eprints.otago.ac.nz/378/, on 7/23/2008.
226. Lobbying Disclosure Act. Retrieved from www.senate.gov/legislative/Lobbying/Lobby_Disclosure_Act/TOC.htm, on 9/25/2008.
227. Landers, S. H., and Sehgal, A. R. (2004). Health care lobbying in the United States. American Journal of Medicine, 116, 474-477.
228. Agnew, B. (1999). Peer review: NIH invites activists into the inner sanctum. Science, 283, 199-2001. Retrieved from www.sciencemag.org/cgi/content/summary/283/5410/1999, on 9/25/2008.
229. Georgia Department of Community Health. Migrant health, homeless and special projects. Retrieved from http://dch.georgia.gov/00/channel_ title/0,2094,31446711_40951017,00.html, on 9/24/2008.ahgeor internet migrant.
230. UK NHS Centre for Involvement, www.nhscentreforinvolvement.nhs.uk, retrieved on 7/22/2008.
231. National Cancer Institute, Office of Advocacy Relations. Retrieved from http://ola.cancer.gov, on 9/24/2008.
232. National Cancer Institute, Office of Advocacy Relations (2008, September 8). Opportunities for public comment. Retrieved from http://ola.cancer.gov/activities/comment, on 9/24/2008. Cochrane Consumer Network. Retrieved from www.cochrane.org/consumers/homepage on 12/21/2008.
233. Walsh-Burke, K. (2001). Self-advocacy training for cancer survivors. Cancer Practice, 7, 297-301.
234. Brashers, D. E., Haas, S. M., Klingle, R. S., and Neidig, J. L. (2000). Collective AIDS activism and individuals' perceived self-advocacy in physician-patient communication. Human Communication Research, 26, 372-402.
235. Mosley, J. (2002). What leads human service nonprofits to be involved in advocacy? Testing a theoretical model that predicts advocacy involvement. Retrieved from http://arnova.omnibooksonline.com/2006/data/papers/PA061226.pdf, on 9/25/2008.
236. Teret, S. P., Alexander, G. R., and Bailey, L. A. (1990). The passage of Maryland's gun law: Data and advocacy for injury prevention. Journal of Public Health Policy, 11, 26-38.
237. Vernick, J. D. (1999). Lobbying and advocacy for the public's health: What are the limits on organizations? American Journal of Public Health, 89, 1425-1429.
238. Gordon, K. B. (2005). Patient education and advocacy groups: A means to better outcomes? Archives of Dermatology, 141, 80-81.
239. Wallack, L. and Dorfman, L. (2001). Media advocacy: A strategy for advancing policy and promoting health. Health Education Quarterly, 23, 293-317.
240. Muscular Dystrophy Association (2005, November 4). NIH names three new muscular dystrophy centers of excellence. Retrieved from www.mda.org/news/051104three_new_centers.html, on 9/24/2008.
241. Methylenetetrahydrofolate reductase polymorphism (MTHFR). Retrieved from http://pathology.mc.duke.edu/coag/MRHFR1flyer2.html, on 7/30/2008.
242. Fowler, B. (1998). Genetic defects of folate and cobalamin metabolism. European Journal of Pediatrics, 157, S60-S66;
243. Lia, D., Pickell, L., Liu, Y., Wu, Q., Cohn, J. S., and Rozen, R. (2005). Maternal methylenetetrahydrofolate reductase deficiency and low dietary folate lead to adverse reproductive outcomes and congenital heart defects in mice. American Journal of Clinical Nutrition, 82, 188-195.
244. Jarvenpaa, J., Pakkila, M., Savolainen, E. R., Perheentupa, A., Jarvela, I., and Ryynanen, M. (2006). Evaluation of Factor V Leiden, prothrombin and methylenetetrahydrofolate reductase gene in patients with severe pregnancy complications in northern Finland. Gynecologic and Obstetric Investigation, 62, 28-32.
245. National Society of Genetic Counselors. Retrieved from www.nsgc.org, on 9/25/2008.
246. Wren, K. (2004, October 21). "Systems biology" focuses on turning masses of genetic data into treatments for disease. Retrieved from www.msnbc.msn.com/id/6291903/, on 9/25/2008.
247. Condit, C. M., Dubriwny, T., Lynch, J., and Parrott, R. (2004). Lay people's understanding of and preference against the word "mutation." American Journal of Medical Genetics, 130A, 245-250.
248. Adamzik, M., Frey, U. H., Riemann, K., Sixt, S., Lehmann, N., Siffert, W., and Peters, J. (2008). Factor V Leiden mutation is associated with improved 30-day survival in patients with acute respiratory distress syndrome. Critical Care Medicine, 36, 177-179.
249. Kerlin, B. A., Yan, S. B., Isermann, B. H., Brandt, J. T., Sood, R., Basson, B. R., Joyce, D. E., Wiler, H., and Dhainaut, J. (2003). Survival advantage associated with heterozygous Factor V Leiden mutation in patients with severe sepsis and in mouse endotoxemia. Blood, 102, 3085-3092.
250. Human Genome Project information: Pharmacogenomics. Retrieved from www.ornl.gov/sci/techresources/Human_Genome/medicine/pharma. shtml, on 9/26/2008.
251. Coumadin. Retrieved from www.rxlist.com/coumadin-drug/article.htm, on 9/25/2008.
252. Heck, A. M., DeWitt, B. A., and Lukes, A. (2000). Potential interactions between alternative therapies and warfarin. American Journal of Health-Systems Pharmacy, 57, 1221-1230.
253. PT and INR. Retrieved from http://labtestsonline.org/understanding/analytes/pt/test.html, on 9/25/2008.
254. Rettie, A. N. (2008). Pharmacogenomics of 4-hydroxycoumarin anticoagulants. Drug Metabolic Review, 40, 355-375.
255. Yaktine, A. L., and Pool, R. (2007). Nutrigenomics and Beyond: Informing the future-Workshop summary. Institute of Medicine Report. Washington, DC: National Academies Press.
256. Goldman, D., Oroszi, G., and Ducci, F. (2005). The genetics of addictions: Uncovering the genes. Focus, 4, 401-415.
257. Lerman, C., Shields, P. G., Wileyto, E. P., Audrain, J., Pinto, A., Hawk, L., Krishnan, S., and Epstein, L. (2002). Pharmacogenetic investigation of smoking cessation treatment. Pharmacogenetics, 12, 627-634.
258. Murff, H., Byrne, D., and Syngal, S. (2004). Cancer risk assessment: Quality and impact of the family history interview. American Journal of Preventive Medicine, 27, 239-245.
259. Goldstein, A. M., Stacey, S. N., Olafsson, J. H., Jonsson, G. F., Helgason, A., Sulem, P., Sigurgeirsson, B., Benediktsdottir, K. R., Thorisdottir, K., Ragnarsson, R., Kjartansson, J., Kostic, J., Masson, G., Kristjansson, K., Gulcher, J. R., Kong, A., Thorsteinsdottir, U., Rafnar, T., Tucker, M. A., and Stefansson, K. (2008). CDKN2A mutations and melanoma risk in the Icelandic population. Journal of Medical Genetics, 45, 284-285.
260. Finkler, K. (2000). Experiencing the New Genetics: Family and kinship on the medical frontier. Philadelphia, PA: University of Pennsylvania Press.
261. Juengst, E. T., Genetic testing and the moral dynamics of family life. Public Understanding of Science, 8, 193-205.
262. Korobkin, R., and Rajkumar, R. (2008). The Genetic Information Nondiscrimination Act-a half-step toward risk sharing. New England Journal of Medicine, 359, 335-337.
263. Pontious, J. M. (2002, January). Understanding the "worried well"-commentary. Journal of Family Practice, 51, 30.
264. Henderson, L., and Kitzinger, J. (1999). The human drama of genes: "hard" and "soft" representations of breast cancer genetics. Sociology of Health and Illness, 21, 560-578.
265. Hoskins et al. (1995). See 174 above.
266. Duncan, V. J., Parrott, R. L., and Silk, K. J. (2001). African American women's perceptions of the role of genetics in breast cancer risk. American Journal of Health Studies, 17, 50-58.
267. Andrykowski, M. A., Munn, R. K., and Studts, J. L. (1996). Interest in learning of personal genetic risk for cancer: A general population survey. Preventive Medicine, 25, 527-536.
268. SYNGENE. Retrieved from www.syngene.com, on 9/25/2008.
269. Identity theft-A primer. Retrieved from www.privcom.gc.ca/id/primer_e.asp, on 8/2/2008; More about identity theft: What is it? Facts and figures. Retrieved from www.europ-assistance.co.uk/Template. aspx?ID=229, on 8/2/2008.
270. Schoen, C., Osborn, R., Huynh, P. T., Doty, M., Peugh, J., and Zapert, K. (2006). On the front lines of care: Primary care doctors' office systems, experiences, and views in seven countries. Health Affairs, 25, 555-571.
271. The medical identity theft information page. Retrieved from www. worldprivacyforum.org/medicalidentitytheft.html, on 9/25/2008.
272. MIB (formerly the Medical Information Bureau). Retrieved from http://survivorshipatoz.org/sub/php?aid=987, on 7/22/2008; MIB Privacy policy. Retrieved from www.mib.com/html/mib_privacy_policy.html, on 4/15/2008; Your medical records: Make sure your medical profile is a healthy, accurate description of you. Retrieved from http://searchenginez.com/medical_records_usa.html, on 7/22/2008.
273. Medids.com Medical card generation form. Retrieved from www. medids.com/phorm/phorm.php, on 9/26/2008.
274. Struewing, J. P., Hartge, P., Wacholder, S., Baker, S. M., Berlin, M., McAdams, M., Timmerman, M. M., Brody, L. C., and Tucker, M. A. (1997). The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. New England Journal of Medicine, 336, 1401-1408.
275. National biospecimen network, Retrieved from http://biospecimens. cancer.gov/biospecimen/network/, on 9/25/2008.
276. Secretary's Advisory Committee on Genetics, Health, and Society (2007). Policy issues associated with undertaking a new large US population cohort study of genes, environment, and disease. Retrieved from www4.od.nih. gov/oba/sacghs/reports/SACGHS_LPS_report.pdf, on 12/19/2007.